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Abstract
Background: Frailty in older adults is a condition characterised by a loss or reduction in physiological reserve
resulting in increased clinical vulnerability. However, evidence suggests that frailty may be modifiable, and
identifying frail older people could help better target specific health care interventions and services.
Methods: This was a regional longitudinal study to develop a frailty index for older adults living in Canterbury New
Zealand. Participants included 5586 community dwelling older people that had an interRAI Minimum Data Set
(MDS-HC) Home Care assessment completed between 2008 and 2012. The outcome measures were mortality and
entry into aged residential care (ARC), after five years.
Results: Participants were aged between 65 and 101 (mean age was 82 years). The five-year mortality rate,
including those who entered ARC, for this cohort was 67.1% (n = 3747). The relationship between the frailty index
and both mortality and entry into ARC was significant (P < 0.001). At five years, 25.1% (n = 98) of people with a
baseline frailty of < 0.1 had died compared with 28.2% (n = 22) of those with a frailty index of ≥0.5 (FS 5).
Furthermore, 43.7% (n = 171) of people with a frailty index of < 0.1 were still living at home compared to 2.6% (n = 2)
of those with a frailty index of ≥0.5.
Conclusion: A frailty index was created that predicts mortality, and admission into ARC. This index could help
healthcare professionals and clinicians identify older people at risk of health decline and mortality, so that
appropriate services and interventions may be put in place.
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Background
Frailty is considered a condition in older people charac-
terised by a loss of physiological reserve, which causes
increased clinical vulnerability [1–3].
Frail older adults are vulnerable to changes in their
health status to the extent that any assault on the body,
such as a minor infection, or a fall can have dispropor-
tionately negative outcomes [4, 5]. A measure of individ-
ual levels of frailty is needed to guide decision making,
for example, when clinicians are considering treatment
options in the aftermath of an acute episode or event,
particularly as evidence suggests that frailty may be
modifiable [6]. Identifying frail older adults would, there-
fore, help target specific health interventions and
services needed to improve outcomes for this vulnerable
cohort [1].
While there is a strong relationship between frailty
and chronological age, frailty status is only one of many
important factors that determine outcome; others
include personal resources, social support and environ-
mental factors, illness acuity and severity [7].
The measure of frailty has been considered using a
phenotype model whereby the presence or absence of a
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pre defined set of five specific signs and symptoms are
used to measure the degree of frailty of a specific indi-
vidual [8]. Alternatively, frailty has been viewed from the
perspective of an accumulation of deficits in the form of
a frailty index [9]. A robust frailty index requires a sig-
nificant number of individual items which are utilised to
record deficit accumulation, and which are recorded as a
score or index. This can also then be monitored in sub-
sequent assessments to record the effectiveness or other-
wise of specific interventions aimed at reducing an
individual’s level of frailty [10].
A frailty index was recently developed using a stan-
dardised assessment of patients in acute care in
Australia: the interRAI acute care (AC) instrument
[6]. Using the methodology of Searle et al., 2008, [11]
specific variables, common to all interRAI instru-
ments, were identified within the assessment as
potential health deficits. The interRAI-AC assessment
used in that study is part of a validated interRAI suite
of assessment tools, which also includes the
Minimum Dataset-Homecare (MDS-HC) assessment
[12–14]. The different interRAI tools are specifically
designed so that core questions are the same and as a
consequence a person’s health status can be tracked
across different health settings using the appropriate
interRAI assessment [15]. The MDS-HC assessment
(recently updated and renamed as the interRAI
Homecare assessment) is used in New Zealand to aid
care of all older people living at home, who require
publicly-funded community support or assessment for
government-funded long-term residential care [16].
The MDS-HC has been demonstrated to be a valid
and reliable electronic assessment tool. A detailed
account of its successor, the interRAI-HC assessment
instrument, has been described previously [16]. It in-
cludes 236 standardised questions analysing all aspects
of an older person’s life [16]. Anyone requiring public
funding for health services in New Zealand is required
to undergo a needs assessment. An individual can be
referred by health professionals such as their general
practitioner, hospital-based professionals or community
health workers. Generally, individuals requiring home
care services are referred by a general practitioner or
other health professional. A trained assessor visits the
individual in their own home to conduct the home care
assessment, the assessor spends time asking questions
from the assessment, and items within the assessment
include standardised responses with definitions and
observational time periods. Assessors also refer to exter-
nal health information such as patient records to ensure
a complete and accurate picture of the individual’s
health at time of assessment [15].
Using the recent Australian Frailty Index as a frame-
work for our study, [6] we aimed to develop and validate
a frailty score for the Canterbury, New Zealand commu-
nity dwelling older people using local MDS-HC data.
Methods
A regional longitudinal study was used to develop a
frailty scale for older adults living in Canterbury, New
Zealand. Outcome measures were mortality and entry
into aged residential care (ARC) over a 5-year period.
All data were anonymised. Ethics permission was
granted by the New Zealand Ministry of Health and
Disability Ethics Committee (14/STH/140).
Participants included 5586 community dwelling older
people who had a MDS-HC assessment completed
between 2008 and 2012, while living in the Canterbury
province of New Zealand.
The MDS-HC is a standardised, geriatric, home care
assessment consisting of over 200 questions, which are
used to guide individual care planning. Assessments are
conducted by trained assessors and each assessment is
recorded electronically. Assessors visit the patient in
person and ask questions, perform physical assessments
and use up to date medical records.
Answers to 42 questions from the MDS-HC assess-
ment were selected as variables in this study. The
criteria for variable deficits from a recent Australian
study were used in the selection of these variables
[6]. Variables were recoded into deficits as described
in the supplementary section. Most of the questions
used in the frailty index were recorded on a binary
scale of 0 or 1 where 1 represents the presence of
the deficit and 0 represents the absence. For example,
when a person’s memory was assessed, it was
recorded as 0 =Memory is fine or 1 =Memory prob-
lem. These variables were directly translated into
Table 1 Frailty index ranges
Failty index ranges 0-0.99 0.1-0.19 0.2-0.29 0.3-0.39 0.4-0.49 ≥ 0.5
Frailty scale 0 1 2 3 4 5
Total^ (%) 391 (7.0) 1960 (35.1) 1993 (35.7) 877 (15.7) 287 (5.1) 78 (1.4)
Female* (%) 198 (50.6) 1191 (60.8) 1265 (63.5) 551 (62.8) 178 (62) 45 (58)
Male+ (%) 193 (49.4) 769 (39.2) 728 (36.5) 326 (37.2) 109 (38) 33 (42)
Mean age 80.5 81.2 82.2 83.6 83.0 83.9
^Total people = 5586; *total female = 3428 (61%); +total male = 2158 (38.1%)
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Table 2 Patient characteristics
Variable (Deficit score) Frequency (%)







































Repetitive anxious complaints, concerns
0 4783 (85.6)
0.5 384 (6.9)
Table 2 Patient characteristics (Continued)











Changes in behaviour symptoms
0 5320 (95.2)
1 266 (4.8)
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Table 2 Patient characteristics (Continued)











































Table 2 Patient characteristics (Continued)
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deficits. For ordinal and continuous variables, the
answers were generally graded into deficits between 0
and 1, such as 0, 0.5, and 1. Thirty-eight of the 42
original variables were directly recoded into 38 poten-
tial deficits, while four variables had weightings on
their deficit score. Three potential deficits were
assigned to “behavioural symptoms”, “number of falls”,
and “number of medications”, and 15 for “count of
disease diagnosis”. This created a maximum score of
62. See Additional file 1 for the list of diseases in the
interRAI-MDS.
The frailty index was calculated by summing the num-
ber of deficits recorded for a patient and dividing by the
total number of possible deficits. This created a frailty
index with a potential range from 0 to 1. In instances
where data was missing, the frailty index was calculated
with an appropriately reduced denominator, so for
example if a person was missing data for one item the
maximum score was reduced to 61. Anyone with a
denominator of less than 30 was omitted from the study.
In this study, there were no missing variables, the entire
cohort had a denominator of 62.
For comparative purposes, the 0–1 frailty index was
recoded into a 6-point frailty scale, where each person
was allocated a score between 0 and 5 with 0 being the
least frail and 5 being the frailest (Table 1). The scores
on the scale correspond to the index as follows: Frailty
Scale FS 0 having 0 ≤ FI < 0.1, FS 1 having 0.1 ≤ FI < 0.2,
FS 2 having 0.2 ≤ FI < 0.3, FS 3 having 0.3 ≤ FI < 0.4, FS 4
having 0.4 ≤ FI < 0.5, and FS 5 having FI ≥ 0.5.
Dates of death were provided by the New Zealand
Births, Deaths and Marriages dataset and matched to
encrypted unique national identifier numbers. The NHI
or National Health Index number is the unique person
identifier used throughout the New Zealand public
health system. Residential care entry date was obtained
from the Contracted Care Payment System of the New
Zealand Ministry of Health.
Table 2 Patient characteristics (Continued)
Variable (Deficit score) Frequency (%)
3 2145 (38.4)
Congestive Heart Failure
Not present 4352 (77.9)
Present 157 (2.8)
Present and treated 1077 (19.3)
Coronary Artery Disease
Not present 4227 (75.7)
Present 223 (4.0)
Present and treated 1136 (20.3)
Hypertension
Not present 2775 (49.7)
Present 351 (6.3)
Present and treated 2460 (44.0)
Alzheimer’s
Not present 5375 (96.2)
Present 57 (1.0)
Present and treated 154 (2.8)
Dementia other than Alzheimer’s
Not present 5279 (94.5)
Present 98 (1.8)
Present and treated 209 (3.7)
Parkinsonism
Not present 5328 (95.4)
Present 33 (0.6)
Present and treated 225 (4.0)
Arthritis
Not present 3243 (58.1)
Present 533 (9.5)
Present and treated 1810 (32.4)
Osteoporosis
Not present 4427 (79.3)
Present 212 (3.8)
Present and treated 947 (17.0)
Any psychiatric diagnosis
Not present 4726 (84.6)
Present 160 (2.9)
Present and treated 700 (12.5)
Urinary Tract Infection
Not present 5232 (93.7)
Present 47 (0.8)
Present and treated 307 (5.5)
Cancer
Table 2 Patient characteristics (Continued)
Variable (Deficit score) Frequency (%)
Not present 4792 (85.8)
Present 116 (2.1)
Present and treated 678 (12.1)
Diabetes
Not present 4643 (83.1)
Present 166 (3.0)
Present and treated 777 (13.9)
Emphysema/COPD/Asthma
Not present 4431 (79.3)
Present 173 (3.1)
Present and treated 982 (17.6)
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Normality of the results was tested using the Kolmo-
gorov-Smirnov test. Kaplan–Meier curves were used
to discern the relationships between the frailty scale
and mortality and admission to residential care, after
five years.
Results
The total sample consisted of 5586 Canterbury District
Health Board (CDHB), New Zealand, MDS-HC assess-
ments. Participants were aged between 65 and 101 years,
with a mean age of 82 years (SD 8.6 years). Most were
females (3428; 61.3%) and European New Zealanders
(4837, 86.6%). Individuals appeared to be cognitively
healthy overall, however, over half of participants (2870,
51.4%) experienced a decline in ADLs and the majority
have 2 or more disease diagnoses. The mean age
increased with frailty (Table 1). Table 2 features a count
of deficits used in creating the frailty index.
The frailty index had a mean of 0.27 (SD 0.12) and a
range from 0.01 to 0.7. The index was not normally dis-
tributed (Fig. 1).
The five-year mortality rate was 67.1% (n = 3747). The
relationship between the frailty score and mortality was
significant (χ2 (5) = 332.2; P < 0.001). At five years, 25.1%
(n = 98) of people with a baseline frailty of < 0.1 had died
compared with 28.2% (n = 22) of those with a frailty
index of ≥0.5 (FS 5),(Fig. 2a).
After five years 2670 (47.8%) of people had entered
ARC. The relationship between the frailty index and ad-
missions to residential care was also significant (χ2 (5) =
252.67; P < 0.001). At five years, 43.7% (n = 171) of
people with a baseline frailty index of < 0.1 (FS 0) were
still living at home, compared to 2.6% (n = 2) of those
with a frailty index of ≥0.5 (FS 5),(Fig. 2b).
Discussion
In this study we demonstrated that a frailty index devel-
oped from the interRAI MDS-HC assessment was sig-
nificantly associated with five-year admission to
residential care and mortality.
An Australian study used interRAI (AC) data from
1418 older adults presenting to acute hospitals in
Queensland and Victoria formed the basis of our study
[6].
This Australian study found a slightly higher mean
frailty index (0.32; SD 0.14) than that of our work
(0.27; SD 0.12) [6]. This difference could reflect the
different settings of both studies: acute hospital care
versus community dwelling. However, both studies
had a similar dose response relationship for predicting
mortality.
A recent large UK study, which calculated 36 deficits
from pre-existing primary care health records, developed
an electronic frailty index with four validated levels of
frailty in over 900,000 older people [1]. Outcome mea-
sures over one-, three-, and five-year periods highlighted
good predictive validity for emergency hospital admis-
sion, mortality, and nursing home admission. Survival
rates were lower in our study than the UK study which
could reflect our investigation’s focus on more frail and
vulnerable members of a community dwelling popula-
tion, rather than the general older population. The UK
Fig. 1 Distribution of Frailty Index
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study demonstrated that risk of hospitalisation and
length of hospital stay increased incrementally with the
degree of frailty.
Another study of community dwelling older people
contextualised frailty scores against clinical descriptors,
[17] and found a mean FI of 0.27 for patients who were
mildly frail, with limited dependence on others for
instrumental activities of daily living. This is consistent
with the findings of our study.
The MDS-HC assessment prepopulates the Change
in Health, End Stage Disease (CHESS) score from 12
specific questions to create a 6 point score [18].
Fig. 2 Survival Curves of a Mortality and Grouped Frailty, b Entry to ARC and Grouped Frailty
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Although it is a valuable tool, the CHESS score is a meas-
ure of a person’s health instability rather than frailty and it
focuses on recent changes in an individual’s health and level
of function and does not include longer term indicators
of frailty such as comorbidities and baseline activities of
daily living (ADL) function. The larger number of po-
tential deficits in our score allows for the identification
of modifiable components which could be targeted to
improve outcomes for individuals, such as exercise, nu-
trition programmes, and medication reviews to help
reduce the effects of polypharmacy [7].
There are a number of other validated frailty scales,
[1, 9, 19] but a significant advantage of our study and its
utilisation of MDS-HC data, is that it allows for a compre-
hensive multi-dimensional perspective that aims to cap-
ture the complex nature of frailty without the need for
further time consuming assessment. Furthermore, the fact
that the interRAI suite of assessment tools are used over a
number of different health settings means that individual
levels of frailty using a standardised frailty index can be re-
corded both over time and across a variety of settings.
We acknowledge however, that this study utilised data
from one region in New Zealand and that it may not be
generalisable beyond this region. Additional work using
this data set at a national level may be useful in identifying
any ethnic differences in regard to frailty. Further work
using New Zealand’s national MDS-HC dataset will assist
in understanding this index’s generalisability including
predicting other outcomes such as number and length of
hospital admissions. We did not differentiate between frail
individuals living at home or receiving daily care from
those who live alone, and acknowledge that outcomes
may have been poorer for the latter individuals.
Conclusion
A frailty index was developed from Canterbury’s MDS-HC
assessment data. From the index an easy to use scale was
developed which could aid clinicians identify older people
at risk of health decline and mortality. Frailty is not an inev-
itable part of ageing and nor should it be a barrier to inter-
ventions. It has the potential to be addressed and the
individual’s outlook improved if it is identified early enough
and the appropriate healthcare investigations, or services
are initiated.
Additional file
Additional file 1: RAN. This is a file containing information on how the
frailty index was calculated. (DOCX 29 kb)
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